FDA to Review Triple Combination Tablet for Type 2 Diabetes
The FDA has accepted for review the New Drug Application for an investigational triple combination tablet for the treatment of adults with type 2 diabetes.
Type 2 Diabetes
Improving Care for T2D in Patients With Severe Mental Illness: Expert Q&A
Despite the clear need for improved management of T2D in patients with SMI, there is scant evidence regarding effective treatment strategies for this group.
Next post in Medicine
